Aquestive Therapeutics, Inc. AQST Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 63.5%+5.1pp | 58.3%-1.9pp | 60.3%-0.8pp | 61.1%-7.3pp | 68.4%-0.5pp | |
| Operating margin | -111.2%+48.3pp | -159.5%-30.9pp | -128.6%-9.4pp | -119.2%-43.3pp | -75.9%-22.5pp | |
| Net margin | -137.1%+51.0pp | -188.1%-29.1pp | -158.9%-11.6pp | -147.4%-47.4pp | -100%-23.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×+0.1× | 0.3×0.0× | 0.3×-0.1× | 0.4×-0.1× | 0.5×-0.3× | |
| Liquidity | ||||||
| Current ratio | 4.1×+1.0× | 3.1×-2.8× | 5.9×+2.4× | 3.5×-1.3× | 4.9×+0.2× | |
| Per Share | ||||||
| Book value per share | -$0.28+11.8% | -$0.31-746% | -$0.04+94.9% | -$0.73-14.5% | -$0.64+8.0% | |
| Valuation | ||||||
| Market capitalization | $560.13M+73.5% | $788.14M+16.5% | $676.24M+112% | $318.84M+11.2% | $286.73M-11.7% | |
| Price / sales | 11.1×+5.2× | 17.7×+2.1× | 15.6×+8.4× | 7.2×+1.9× | 5.3×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aquestive Therapeutics, Inc.'s profit margins?
- Aquestive Therapeutics, Inc. (AQST) runs a 63.5% gross margin and a -111.2% operating margin, with a -137.1% net margin.
- Where do Aquestive Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Aquestive Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
